The lab analyst performs a liquid biopsy using a plasma specimen to identify cell–free DNA (cfDNA) or DNA/RNA for a genomic sequence analysis panel. The test evaluates nucleic acid sequence variants, copy number variants, and rearrangements known to impact diagnosis and treatment of solid organ cancers.
For clinical responsibility, terminology, tips and additional info
start codify free trial.